Tirzepatide emerges a groundbreaking therapeutic agent for individuals facing type 2 diabetes. As a dual stimulator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide https://kiarakxzy147728.ssnblog.com/39271733/tirzepatide-a-new-frontier-in-diabetes-treatment